ARTICLE | Clinical News
AF-130: Phase I started
January 18, 2016 8:00 AM UTC
Afferent began a 2-part, double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral AF-130 in about 109 healthy volunteers. The first part will evaluate single ascending doses of AF-130 in ...